Team identifies UGDH as indicator of tumor progression in clinical oncology and cancer biology
A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" has been published in Oncotarget.
Oct 5, 2023
0
6
A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" has been published in Oncotarget.
Oct 5, 2023
0
6
Research and development (R&D) costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not be reflected in ...
Aug 21, 2023
0
1
Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal. ...
Jul 17, 2023
0
1
Dr. Niklas Klümper, resident at the Department of Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr. Jonas Saal, resident at the Medical Clinic ...
Jun 22, 2023
0
29
Among patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), those who received maintenance atezolizumab immunotherapy plus the PARP inhibitor talazoparib ...
Jun 5, 2023
0
2
An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.
Jun 5, 2023
0
76
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
Jun 5, 2023
0
91
The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories (complete or partial response, ...
Jun 3, 2023
0
4
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the ...
Jun 1, 2023
0
2
Results from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the spine did not meet its primary endpoint. Data from the study suggests that ...
Apr 27, 2023
0
5